Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Age and gender as predictors of benefit from aminophylline administration in patients undergoing regadenoson stress myocardial perfusion imaging: a substudy of the ASSUAGE trial.

Rangel MO, Demori RM, Doukky R.

Am J Ther. 2013 Nov-Dec;20(6):622-9. doi: 10.1097/01.mjt.0000434986.92593.8b.

PMID:
24100259
[PubMed - indexed for MEDLINE]
2.

Attenuation of the side effect profile of regadenoson: a randomized double-blind placebo-controlled study with aminophylline in patients undergoing myocardial perfusion imaging and have severe chronic kidney disease--the ASSUAGE-CKD trial.

Doukky R, Rangel MO, Dick R, Wassouf M, Alqaid A, Margeta B.

Int J Cardiovasc Imaging. 2013 Jun;29(5):1029-37. doi: 10.1007/s10554-012-0166-6. Epub 2012 Dec 11.

PMID:
23224354
[PubMed - indexed for MEDLINE]
3.

Attenuation of the side effect profile of regadenoson: a randomized double-blinded placebo-controlled study with aminophylline in patients undergoing myocardial perfusion imaging. "The ASSUAGE trial".

Doukky R, Morales Demori R, Jain S, Kiriakos R, Mwansa V, Calvin JE.

J Nucl Cardiol. 2012 Jun;19(3):448-57. doi: 10.1007/s12350-012-9533-x. Epub 2012 Mar 7.

PMID:
22395779
[PubMed - indexed for MEDLINE]
4.

Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results.

Cerqueira MD, Nguyen P, Staehr P, Underwood SR, Iskandrian AE; ADVANCE-MPI Trial Investigators.

JACC Cardiovasc Imaging. 2008 May;1(3):307-16. doi: 10.1016/j.jcmg.2008.02.003.

PMID:
19356442
[PubMed - indexed for MEDLINE]
Free Article
5.

Comparison of hemodynamic and stress testing variables in patients undergoing regadenoson stress myocardial perfusion imaging to regadenoson with adjunctive low-level exercise myocardial perfusion imaging.

Cabrera R, Husain Z, Palani G, Karthikeyan AS, Choudhry Z, Dhanalakota S, Peterson E, Ananthasubramaniam K.

J Nucl Cardiol. 2013 Jun;20(3):336-43; quiz 344-5. doi: 10.1007/s12350-012-9671-1. Epub 2013 Feb 21.

PMID:
23430361
[PubMed - indexed for MEDLINE]
6.

Considerations when measuring myocardial perfusion reserve by cardiovascular magnetic resonance using regadenoson.

Bhave NM, Freed BH, Yodwut C, Kolanczyk D, Dill K, Lang RM, Mor-Avi V, Patel AR.

J Cardiovasc Magn Reson. 2012 Dec 28;14:89. doi: 10.1186/1532-429X-14-89.

PMID:
23272658
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

The safety and tolerability of regadenoson in patients with end-stage renal disease: the first prospective evaluation.

Doukky R, Rangel MO, Wassouf M, Dick R, Alqaid A, Morales Demori R.

J Nucl Cardiol. 2013 Apr;20(2):205-13. doi: 10.1007/s12350-012-9654-2. Epub 2012 Dec 13.

PMID:
23239416
[PubMed - indexed for MEDLINE]
8.

Comparison of the prognostic value of normal regadenoson with normal adenosine myocardial perfusion imaging with propensity score matching.

Iqbal FM, Hage FG, Ahmed A, Dean PJ, Raslan S, Heo J, Iskandrian AE.

JACC Cardiovasc Imaging. 2012 Oct;5(10):1014-21. doi: 10.1016/j.jcmg.2012.04.009.

PMID:
23058068
[PubMed - indexed for MEDLINE]
Free Article
9.

A strategy of symptom-limited exercise with regadenoson-as-needed for stress myocardial perfusion imaging: a randomized controlled trial.

Parker MW, Morales DC, Slim HB, Ahlberg AW, Katten DM, Cyr G, Mathur S, Ardestani A, Barmpouletos D, Iyah GS, Borer SM, Heller GV.

J Nucl Cardiol. 2013 Apr;20(2):185-96. doi: 10.1007/s12350-012-9641-7. Epub 2012 Nov 28.

PMID:
23188626
[PubMed - indexed for MEDLINE]
10.

Acute myocardial infarction during regadenoson myocardial perfusion imaging.

Shah S, Parra D, Rosenstein RS.

Pharmacotherapy. 2013 Jun;33(6):e90-5. doi: 10.1002/phar.1238. Epub 2013 Mar 7.

PMID:
23471769
[PubMed - indexed for MEDLINE]
11.

Regadenoson use in patients with chronic obstructive pulmonary disease: the state of current knowledge.

Golzar Y, Doukky R.

Int J Chron Obstruct Pulmon Dis. 2014 Jan 22;9:129-37. doi: 10.2147/COPD.S56879. eCollection 2014. Review.

PMID:
24489466
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Regadenoson: review of its established role in myocardial perfusion imaging and emerging applications.

Palani G, Ananthasubramaniam K.

Cardiol Rev. 2013 Jan-Feb;21(1):42-8. doi: 10.1097/CRD.0b013e3182613db6. Review.

PMID:
22643345
[PubMed - indexed for MEDLINE]
13.

Prognostic value of normal regadenoson stress perfusion cardiovascular magnetic resonance.

Freed BH, Narang A, Bhave NM, Czobor P, Mor-Avi V, Zaran ER, Turner KM, Cavanaugh KP, Chandra S, Tanaka SM, Davidson MH, Lang RM, Patel AR.

J Cardiovasc Magn Reson. 2013 Dec 21;15:108. doi: 10.1186/1532-429X-15-108.

PMID:
24359617
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Safety and feasibility of adjunctive regadenoson injection at peak exercise during exercise myocardial perfusion imaging: The Both Exercise and Regadenoson Stress Test (BERST) trial.

Ross MI, Wu E, Wilkins JT, Gupta D, Shen S, Aulwes D, Montero K, Holly TA.

J Nucl Cardiol. 2013 Apr;20(2):197-204. doi: 10.1007/s12350-013-9679-1. Epub 2013 Feb 13.

PMID:
23404232
[PubMed - indexed for MEDLINE]
15.

Comparison of the myocardial blood flow response to regadenoson and dipyridamole: a quantitative analysis in patients referred for clinical 82Rb myocardial perfusion PET.

Goudarzi B, Fukushima K, Bravo P, Merrill J, Bengel FM.

Eur J Nucl Med Mol Imaging. 2011 Oct;38(10):1908-16. doi: 10.1007/s00259-011-1853-6. Epub 2011 Jun 9.

PMID:
21656246
[PubMed - indexed for MEDLINE]
16.

The impact of regimented aminophylline use on extracardiac radioisotope activity in patients undergoing regadenoson stress SPECT myocardial perfusion imaging: a substudy of the ASSUAGE trial.

Ballany W, Mansour K, Morales Demori R, Al-Amoodi M, Doukky R.

J Nucl Cardiol. 2014 Jun;21(3):496-502. doi: 10.1007/s12350-014-9864-x. Epub 2014 Feb 12.

PMID:
24519563
[PubMed - in process]
17.

Coronary vasospasm during a regadenoson stress test.

Bagley SJ, Lilly SM, Litwack AJ.

Cardiol J. 2012;19(1):92-4. No abstract available.

PMID:
22298176
[PubMed - indexed for MEDLINE]
Free Article
18.

Safety of regadenoson, an adenosine A2A receptor agonist for myocardial perfusion imaging, in mild asthma and moderate asthma patients: a randomized, double-blind, placebo-controlled trial.

Leaker BR, O'Connor B, Hansel TT, Barnes PJ, Meng L, Mathur VS, Lieu HD.

J Nucl Cardiol. 2008 May-Jun;15(3):329-36. doi: 10.1016/j.nuclcard.2008.02.009. Epub 2008 Apr 14.

PMID:
18513639
[PubMed - indexed for MEDLINE]
19.

Regadenoson in the detection of coronary artery disease.

Buhr C, Gössl M, Erbel R, Eggebrecht H.

Vasc Health Risk Manag. 2008;4(2):337-40. Review.

PMID:
18561509
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Safety of regadenoson as a pharmacologic stress agent for myocardial perfusion imaging in chronic kidney disease patients not on hemodialysis.

Palani G, Husain Z, Salinas RC, Karthikeyan V, Karthikeyan AS, Ananthasubramaniam K.

J Nucl Cardiol. 2011 Aug;18(4):605-11. doi: 10.1007/s12350-011-9378-8. Epub 2011 May 4.

PMID:
21541818
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk